• Biotechnology: stem cells and regenerative medicine

What are the phases of a clinical trial?

Written with AI (How we create content)Target level: Grade 12Last updated: Report an error
Quick answer

The phases of a clinical trial test a new treatment in people step by step. Phase I checks safety and dose in a small group, phase II asks whether it works, phase III compares it with the standard treatment in hundreds or thousands, and phase IV watches for rare effects after approval. Most candidates fail along the way, which is why unproven treatments are risky.

The topic explained

From the laboratory to people

Before a new treatment reaches patients it is studied in cells and in animals, the preclinical stage. If it looks safe and promising, it enters the phases of a clinical trial, each with its own question, and each started only if the one before went well. For a cell or gene therapy the steps are the same as for a drug, with one difference in the first phase: because the treatment carries real risks and may stay in the body for years, phase I is usually run in patients with the disease rather than in healthy volunteers, as it is for cancer drugs.

A common misreading is that a phase is a stage of the patient's treatment. A phase is a stage of the research: different groups of people take part in each phase, and every one of them must give informed consent, after being told what is known and what is not yet known about the treatment.

Five steps from top to bottom: laboratory and animal tests; phase I asks whether it is safe; phase II asks whether it works; phase III asks whether it is better than current treatment; approval, followed by phase IV.1. Lab and animal tests2. Phase I: safety, dose3. Phase II: does it work4. Phase III: vs. standard5. Approval, then phase IV
The path from the laboratory to approval.

Four questions, four phases

Phase I gives the treatment to a small group, usually 20 to 100 people, to find out whether it is safe and what dose can be given. Phase II, with about 100 to 300 participants, asks whether it works in people with the disease and what side effects appear. Phase III is the large test, with about 300 to 3,000 or more participants in several centers, comparing the new treatment with the current standard. Participants are assigned at random to one treatment or the other, so that the groups differ only in the treatment, a randomized controlled trial.

Approval by a regulator, such as the FDA in the United States, comes only after phase III. Phase IV then follows the treatment in use, because some effects are too rare or too slow to appear among a few thousand people.

A table of the four phases: phase I, 20 to 100 people, safety and dose; phase II, 100 to 300, does it work; phase III, 300 to 3,000 or more, is it better than the standard treatment; phase IV, after approval, rare and late effects.PhasePeopleMain questionI20 to 100safety and doseII100 to 300does it work?III300 to 3,000+better than standard?IVafter approvalrare, late effects
Typical sizes; each trial sets its own.

Most candidates do not make it

Average success rates are about 52% for phase I, 28.9% for phase II and 57.8% for phase III. Of 100 candidates entering phase I, about 52 pass it, 52×0.289≈1552 \times 0.289 \approx 15 pass phase II and 15×0.578≈8.715 \times 0.578 \approx 8.7 pass phase III: roughly nine in a hundred. So about 90% of treatments that looked good in the laboratory fail in people, mostly because they do not work well enough or cause harm. A failure in phase III, after years of work and thousands of participants, is the most costly kind. Students often read this as a failure of science. It is the system working: the phases exist to catch these failures before a treatment is given to many people.

A bar chart of what happens to 100 candidate treatments: 100 enter phase I, 52 pass it, 15 pass phase II and 8.7 pass phase III.candidates20406080100010052158.7
Bars from left: at the start, then after passing phases I, II and III. Computed from average success rates of 52%, 28.9% and 57.8%.

Who checks, and why unproven clinics are a danger

In Israel, every trial in a hospital must be approved by the hospital's Helsinki committee, and some, such as many genetic studies, also by the Ministry of Health's supreme Helsinki committee. Elsewhere, similar ethics boards and regulators do the same job.

Some private clinics sell stem cell treatments that have not passed these phases. As of 2024 the only stem cell therapy approved by the FDA and widely practiced is blood stem cell transplantation, used for blood cancers and some other blood diseases. In 2021, products sold in the United States as stem cell treatment caused serious infections in at least 20 patients, and regulators have warned and sued clinics for unproven claims. A treatment that skips trials skips the evidence that it is safe and works; questions about any treatment belong with a doctor.

Free printable worksheet

Practice: phases of a clinical trial

For 12th grade biotechnology students. Answer each question from the sheet, show your calculations, then check your answers.

Free, no sign-up. The answer key prints on the second page. Regenerating a new worksheet on the same topic needs a free account.

Free printable worksheetlessoons.com
Practice: phases of a clinical trialName:
  1. What is tested in the preclinical stage, and why does it come first?

  2. Fill in step 3 and say about how many people take part in it.

    The five steps from the laboratory to approval with step 3 replaced by a question mark.1. Lab and animal tests2. Phase I: safety, dose3. ?4. Phase III: vs. standard5. Approval, then phase IV
  3. Fill in the main questions of phases I and III.

    The table of the four phases with the main question of phases I and III hidden.PhasePeopleMain questionI20 to 100?II100 to 300does it work?III300 to 3,000+?IVafter approvalrare, late effects
  4. Fill in the number of the 100 candidates that pass phase II, and show the calculation.

    The bar chart of 100 candidates with the number that pass phase II replaced by a question mark.candidates20406080100010052?8.7
  5. Using the same rates, how many of 200 candidates would reach phase III?

  6. Why is phase I of a cell therapy usually run in patients and not in healthy volunteers?

  7. Why is phase IV needed even after a treatment is approved?

More topics and worksheets at lessoons.com© 2026 Lessons

Common questions

What are the four phases of a clinical trial?

Phase I tests safety and dose in a small group; phase II tests whether the treatment works; phase III compares it with the standard treatment in a large group; phase IV follows it after approval.

How many people are in a phase III trial?

Usually about 300 to 3,000 or more, often in several centers, so that differences between the new and the standard treatment can be measured reliably.

Why do most treatments fail in clinical trials?

Most fail because they do not work well enough in people or cause harm that the laboratory did not reveal. About 90% of candidates that enter phase I are never approved.

What is a randomized controlled trial?

A trial in which participants are assigned by chance to the new treatment or to a comparison, so that the groups differ only in the treatment and the result can be trusted.

Are stem cell clinics that advertise cures safe?

Treatments that have not passed clinical trials have no proven benefit and have caused harm, including serious infections. Any decision about a treatment should be made with a doctor.

Still have a question? Ask Lessi

Any question about this subject. Lessi answers right here, step by step.

Try asking

Asking needs a free account; your question is kept while you sign up. Answers are written by AI and can contain mistakes. Lessi doesn’t give medical or legal advice.

Learn it with a teacher

Learn this topic live with Lessi

Lessi, the AI teacher, explains it out loud on a board, with short quizzes, at your pace. The first 60 minutes are free.